Daito Pharmaceutical Co Ltd
TSE:4577
Daito Pharmaceutical Co Ltd
Cost of Revenue
Daito Pharmaceutical Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Daito Pharmaceutical Co Ltd
TSE:4577
|
Cost of Revenue
-¥38.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cost of Revenue
-¥1.6T
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-12%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cost of Revenue
-¥426B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cost of Revenue
-¥660.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cost of Revenue
-¥339.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Cost of Revenue
-¥345.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
Daito Pharmaceutical Co Ltd
Glance View
Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.
See Also
What is Daito Pharmaceutical Co Ltd's Cost of Revenue?
Cost of Revenue
-38.3B
JPY
Based on the financial report for Nov 30, 2024, Daito Pharmaceutical Co Ltd's Cost of Revenue amounts to -38.3B JPY.
What is Daito Pharmaceutical Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-4%
Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for Daito Pharmaceutical Co Ltd have been -4% over the past three years , -2% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet